Primary Cells Market to Grow with a CAGR of 5.25% through 2029
Increasing prevalence of
chronic diseases and rising drug discovery and development are factors driving the
Global Primary Cells Market in the forecast period 2025-2029.
According to TechSci Research report, “Primary
Cells Market – Global Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2029”, the Global Primary Cells Market stood at USD 1.52
billion in 2023 and is anticipated to grow with a CAGR of 5.25% in the forecast
period, 2025-2029. The global primary cells market has
witnessed remarkable growth in recent years, driven by various factors that are
reshaping the landscape of life sciences and medical research. Primary cells
are non-transformed cells that are isolated directly from living tissues,
offering a more accurate representation of in vivo conditions compared to
immortalized cell lines. Researchers and biopharmaceutical companies have
increasingly recognized the importance of primary cells in various
applications, ranging from drug discovery and development to regenerative
medicine. One of the primary drivers of the global primary cells market is the
rising demand for personalized medicine. Personalized medicine involves
tailoring medical treatment to an individual's unique genetic makeup, and
primary cells play a crucial role in this approach. Researchers use primary
cells to develop patient-specific models for drug screening and testing,
thereby enabling the development of treatments that are more effective and with
fewer side effects.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Primary Cells Market”
The prevalence of chronic diseases such
as cancer, diabetes, and cardiovascular disorders is on the rise globally. This
has spurred the demand for primary cells, as they are essential for studying
the underlying mechanisms of these diseases, identifying potential therapeutic
targets, and testing new drug candidates. Primary cell-based research is
instrumental in advancing our understanding of complex diseases and developing
innovative treatment options.
Regenerative medicine is a rapidly
evolving field that holds the promise of repairing or replacing damaged tissues
and organs. Primary cells, particularly stem cells, are critical for
regenerative medicine applications. Their use in tissue engineering and organ
transplantation research is driving the growth of the primary cells market. As
regenerative medicine continues to gain momentum, the demand for primary cells
is expected to increase further.
The pharmaceutical industry relies
heavily on primary cells for drug discovery and development. Primary cell
cultures are used to assess the safety and efficacy of potential drug
candidates, reducing the likelihood of adverse effects in later stages of drug
development. As the pharmaceutical sector continues to expand and innovate, the
demand for primary cells for in vitro testing is expected to remain strong.
The Global Primary Cells Market is segmented into product,
origin, end user and company.
Based on end user, the Pharma Biotech segment has emerged
as the predominant market leader. Pharmaceutical and biotechnology companies
are increasingly relying on primary cells to screen potential drug candidates.
The ability to study the effects of drugs on primary cells in a more
physiologically relevant environment can significantly reduce the failure rate
in clinical trials. Stem cells, a type of primary cell, are at the
forefront of regenerative medicine. The pharmaceutical and biotech industries
are heavily invested in developing stem cell-based therapies to treat a wide
range of diseases, such as diabetes, heart disease, and neurodegenerative
disorders.
Based on region, North America segment is expected to
grow during the forecast period. North American governments, private
enterprises, and funding agencies have consistently invested in research and
development. The significant financial resources allocated to primary cell
research and its applications have propelled the region's dominance. This
investment has led to breakthroughs in cell therapy, regenerative medicine, and
the development of cutting-edge therapies for various diseases.
Major companies operating in Global Primary Cells Market
are:
- AllCells
- ZenBio Inc.
- PromoCell
- Thermo Fisher Scientific Inc.
- Cell Biologics Inc.
- STEMCELL Technologies Inc.
- Merck KGaA
- American Type Culture Collection (ATCC)
Download Free Sample Report
Customers can also request for 10% free customization
on this report
“The global
primary cells market is experiencing robust growth, primarily driven by the
increasing demand for personalized medicine, the prevalence of chronic
diseases, advancements in regenerative medicine, and the expanding
biopharmaceutical industry. Additionally, technological innovations and rising
investments in life sciences research are contributing to the market's
momentum. As the importance of primary cells in various applications continues
to grow, the market is expected to witness further expansion and innovation in
the years to come, making it an exciting and dynamic sector within the life
sciences industry.” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based management consulting firm.
“Primary Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), By Origin (Human Primary Cells, Animal Primary Cells), By End user (Pharma Biotech, CROS, Academia), By Region and Competition 2019-2029F”, has evaluated
the future growth potential of Global Primary Cells Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Primary Cells Market.
Contact Us-
TechSci Research LLC
420 Lexington Avenue, Suite
300,
New York, United States-
10170
M: +13322586602
Email: [email protected]
Website: www.techsciresearch.com